Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Leap Therapeutics Q2 2024 GAAP EPS $(0.52) Misses $(0.43) Estimate, Cash And Cash Equivalents Totaled $78.5M At June 30, 2024, Expected To Fund Leap's Operating And Capital Expenditures Into Q2 Of 2026

Author: Benzinga Newsdesk | August 12, 2024 07:25am

Posted In: LPTX